Danaher Corporation
DHR · NYSE · USD · Healthcare
Price
+4.2% since 21/09/20261 month · High $233.02 (-3.7%) · Low $209.23
What is happening
Danaher Corporation has fallen 4% since its 6-week high on 15/10/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayHow deep is the dip?
- from the 6-week high-3.7%
Highest daily price: $233.02 on 15/10/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-7.6%
Highest price in 52 weeks: $242.80 (Yahoo)
Marking places no order – it only helps you keep track.
Catalysts
1 h ago- News, last 10 days
- no recent news
- Next earnings
- 21/10/2026 · in 1 days
- Last report
- 21/07/2026 +5.3% vs estimate
Earnings within 3 days: results can move the price either way. The score is held back until they are out.
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
- Headquarters:
- Washington, United States
- 52-week range:
- $160.93 – $242.80
- Website:
- danaher.com
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
